Recently published in vitro GABA uptake assay data provides evidence that some of the published schizophrenia SLC6A1 missense variants, as well as two of the three missense variants reported in the new cases, confer loss-of-function effects on GAT-1 protein leading to reduced GABA uptake32. Here, SLC6A1 is linked to schizophrenia.